Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Actinium Completes Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial

americanpharmaceuticalreviewApril 02, 2021

Tag: Actinium , AML , Actimab-A , Venetoclax , Actinium-225

PharmaSources Customer Service